Which medications can cause medication-induced mania?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications That Cause Drug-Induced Mania

Corticosteroids, levodopa and other dopaminergic agents, antidepressants (particularly in bipolar disorder), sympathomimetic amines including amphetamines, and certain antibiotics are the primary culprits for medication-induced mania.

High-Risk Medications with Definite Evidence

Corticosteroids

  • Steroids are among the most common causes of drug-induced mania, with dose-dependent risk of psychiatric side effects including mania, depression, and psychosis 1, 2, 3.
  • Exogenous corticosteroids cause dysregulation of corticosteroid signaling and neurotransmitters, particularly dangerous in patients with underlying (even subthreshold) bipolar disorder 3.

Dopaminergic Agents

  • Levodopa and other anti-Parkinsonian dopaminergic drugs have definite propensity to induce manic symptoms 1, 2.
  • The mechanism involves effects on monoaminergic systems 1.

Amphetamines and Sympathomimetics

  • High-dose prescription amphetamines (>30 mg dextroamphetamine equivalents) carry a 5.28-fold increased risk of psychosis or mania 4.
  • A clear dose-response relationship exists, with higher doses conferring substantially greater risk 4.
  • Sympathomimetic amines more broadly are established triggers for manic episodes 1, 2.
  • Methylphenidate, in contrast, does not show increased risk of mania or psychosis compared to no use 4.

Antidepressants

  • Tricyclic antidepressants and monoamine oxidase inhibitors can induce mania specifically in patients with pre-existing bipolar disorder 2, 5.
  • Recent meta-analysis found no antidepressant significantly increased switch to mania compared to placebo, though venlafaxine showed the highest (non-significant) risk estimate (RR 4.53) 6.
  • The evidence base is stronger for add-on therapy than monotherapy 6.

Moderate-Risk Medications with Probable Evidence

Antibiotics

  • Antitubercular agents, macrolides, and quinolones are the most commonly implicated antibiotic classes 7.
  • 47 published cases exist, though the paucity of reports suggests this is a rare phenomenon 7.
  • Patients ranged from 3-77 years (mean 40), with two-thirds being male 7.

Tramadol

  • This synthetic opioid has been associated with mania activation, likely through mechanisms involving monoamine neurotransmission and increased oxidative stress 5.

Other Agents

  • Anabolic-androgenic steroids have definite propensity to cause mania 2.
  • Thyroxine, iproniazid, isoniazid, chloroquine, baclofen, alprazolam (a triazolobenzodiazepine), and captopril have probable but less scientifically secure evidence 1, 2.

Atypical Antipsychotics (Controversial)

  • Case reports exist for olanzapine, quetiapine, ziprasidone, aripiprazole, and others, but well-designed clinical trials show non-superiority to placebo for inducing mania 8.
  • Most reported cases (24 of 28) occurred in schizophrenia patients, not mood disorder patients 8.
  • This appears to be a marginal phenomenon not mediated by antidepressant properties 8.

Key Clinical Characteristics

  • Common presenting features include increased activity, rapid speech, elevated mood, and insomnia 1.
  • Patients often have prior history, family history, or current symptoms of mood disturbance at baseline 1.

Management Approach

Discontinue or reduce the dose of the causative agent as first-line management 1, 2, 7.

  • Discontinuation of the inciting drug and treatment with neuroleptic agents are equally efficacious 1.
  • Lithium treatment was less effective than discontinuation or neuroleptics 1.
  • For antibiotics specifically, discontinue the suspicious drug and treat manic symptoms with standard approaches 7.

Critical Pitfall

Avoid abrupt discontinuation of mood stabilizers (e.g., valproate, lithium) as this carries high risk of seizure recurrence and mood-episode relapse; gradual tapering by approximately 25% every two weeks is required 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.